NASDAQ: ICCC
Immucell Corp Stock Ownership - Who owns Immucell?

Insider buying vs selling

Have Immucell Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Scott TomscheDirector2024-08-282,186$3.55
$7.76kBuy
David Scott TomscheDirector2024-08-236,005$3.55
$21.32kBuy
David Scott TomscheDirector2024-08-2210,000$3.55
$35.50kBuy
David Scott TomscheDirector2024-08-193,172$3.67
$11.64kBuy
David Scott TomscheDirector2024-08-164,811$3.72
$17.88kBuy
David Scott TomscheDirector2024-08-152,017$3.57
$7.19kBuy

1 of 1

ICCC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ICCC insiders and whales buy or sell their stock.

ICCC Shareholders

What type of owners hold Immucell Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Norman H. Pessin7.24%650,000$3.58MInsider
Jonathan E. Rothschild5.72%514,003$2.83MInsider
David Scott Tomsche2.64%236,883$1.30MInsider
Vanguard Group Inc2.51%225,595$1.24MInstitution
Michael F. Brigham2.28%204,752$1.13MInsider
Joseph H. Crabb1.59%142,845$785.65kInsider
Renaissance Technologies LLC1.53%136,989$753.44kInstitution
Cresset Asset Management LLC1.47%132,001$726.01kInstitution
Dauntless Investment Group LLC1.46%131,195$721.57kInstitution
Bleichroeder LP1.13%101,594$558.77kInstitution

1 of 3

ICCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ICCC13.42%21.29%Net Buying
GANX7.14%4.69%Net Buying
CUE19.02%9.15%Net Buying
SKYE3.44%96.56%Net Selling
PDSB9.34%26.04%Net BuyingNet Buying

Immucell Stock Ownership FAQ

Who owns Immucell?

Immucell (NASDAQ: ICCC) is owned by 13.42% institutional shareholders, 21.29% Immucell insiders, and 65.30% retail investors. Norman H. Pessin is the largest individual Immucell shareholder, owning 650,000.00 shares representing 7.24% of the company. Norman H. Pessin's Immucell shares are currently valued at $3.50M.

If you're new to stock investing, here's how to buy Immucell stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.